Companies /Healthcare

Annovis Bio Inc

NYSE: ANVS Biotechnology
$1.12
▼ $0.02 (−1.75%) today
Markets closed · 9:52pm ET
Today · % change

Fundamentals

Market Cap
$48.6M
EPS (TTM)
$-1.75
52-Week Range
$1 – $6
Street Target
$10.50

About Annovis Bio

Annovis Bio, Inc., a clinical-stage drug platform company, develops drugs to treat neurodegeneration. The company is headquartered in Berwyn, Pennsylvania.

ANVS Coverage